biological source
mouse
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
4C7, monoclonal
mol wt
calculated mol wt 47.23 kDa, observed mol wt ~50 kDa
purified by
using protein G
species reactivity
human, chicken, mouse
packaging
antibody small pack of 100
technique(s)
electron microscopy: suitable, immunocytochemistry: suitable, immunofluorescence: suitable, immunohistochemistry: suitable, immunoprecipitation (IP): suitable, western blot: suitable
isotype
IgG1κ
epitope sequence
Unknown
Protein ID accession no.
UniProt accession no.
storage temp.
2-8°C
target post-translational modification
unmodified
Quality Level
Gene Information
chicken ... HNF-3beta(395539)
General description
Hepatocyte nuclear factor-3beta (UniProt: Q9PWP8; also known as HNF-3 beta, FOXA2) is encoded by the HNF-3beta gene (Gene ID: 395539) in Chicken. FoxA2 belongs to the forkhead family of transcription factors that uses a modified helix-turn-helix motif to bind DNA as a monomer. Its DNA binding domain is localized in amino acids 151-245. It is expressed very early during development and is involved in the development of several tissues, including liver, pancreas, lung, prostate, and the nervous system. In mouse embryo, FoxA2 expression is initiated during gastrulation in the node, notochord, and floor plate. Its induction in neural plate cells is an early response to notochord-derived signals and its ectopic expression induces floor plate differentiation. In the ventral mesencephalon and cerebellum, it is co-expressed with Engrailed homeoproteins - En1 and En2, which raises the possibility that the two transcription factors interact to regulate common target genes. FoxA2 expression is observed in different regions of the developing nervous system. Along with FoxA1, it is reported to be crucial for the specification and differentiation of dopamine neurons during embryonic development. FoxA2 also functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers. It is shown to be a key target of TGF-β1 in controlling epithelial-to-mesenchymal transition (EMT) in lung cancer cells. (Ref.: Rausa, FM., et al. (2020). Mol. Cell. Biol. 20(21); 8264-8282; Domanskyi, A., et al (2014). Front. Cell. Neurosci. 8; 275; Tang, Y., et al. (2011). Cell Res. 21(2); 316-326; Foucher, I., et al. (2003). Development 130(9); 1867-1876; Ericson, J., et al. (1996). Cell. 87(4); 661-673).
Immunogen
Recombinant Chicken Rhodopsin (1-6).
Application
Quality Control Testing
Evaluated by Western Blotting in HepG2 cell lysate.
Western Blotting Analysis: A 1:500 dilution of this antibody detected FoxA2/HNF-3b, in HepG2 cell lysate.
Tested Applications
Electrophoretic Mobility Shift Assay: A representative lot detected FoxA2/HNF-3b in Electrophoretic Mobility Shift Assay (EMSA) (Foucher, I., et al. (2003). Development. 130(9): 1867-76).
Immunofluorescence Analysis: A representative lot detected FoxA2/HNF-3b in Immunofluorescence applications (Camp, D., et al. (2014). Development. 141(20): 3879-88; Hoelzl, M.A., et al. (2017). Dev Biol. 429(1): 132-146).
Immunoprecipitation Analysis: A representative lot immunoprecipitated FoxA2/HNF-3b in Immunoprecipitation applications (van den Brink, G.R., et al. (2001). Gastroenterology. 121(2):317-28).
Immunohistochemistry Applications: A representative lot detected FoxA2/HNF-3b in Immunohistochemistry applications (Ericson, J., et al. (1996). Cell. 87(4):661-73; Kwon, O., et al. (1998). J Clin Invest. 101(10):2054-64; Rousa, F.M., et al. (2000). Mol Cell Biol. 20(21):8264-82; van den Brink, G.R., et al. (2001). Gastroenterology. 121(2):317-28; Camp, D., et al. (2014). Development. 141(20):3879-88; Hoelzl, M.A., et al. (2017). Dev Biol. 429(1):132-146; Amarnath, S., et al. (2017). J Cell Sci. 130(1):119-131).
Immunocytochemistry Analysis: A representative lot detected FoxA2/HNF-3b in Immunohistochemistry applications (Nagase, T., et al. (2009). Dev Dyn. 238(5):1118-30).
Western Blotting Analysis: A representative lot detected FoxA2/HNF-3b in Western Blotting applications (Rousa, F.M., et al. (2000). Mol Cell Biol. 20(21):8264-82; van den Brink, G.R., et al. (2001). Gastroenterology. 121(2):317-28).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Evaluated by Western Blotting in HepG2 cell lysate.
Western Blotting Analysis: A 1:500 dilution of this antibody detected FoxA2/HNF-3b, in HepG2 cell lysate.
Tested Applications
Electrophoretic Mobility Shift Assay: A representative lot detected FoxA2/HNF-3b in Electrophoretic Mobility Shift Assay (EMSA) (Foucher, I., et al. (2003). Development. 130(9): 1867-76).
Immunofluorescence Analysis: A representative lot detected FoxA2/HNF-3b in Immunofluorescence applications (Camp, D., et al. (2014). Development. 141(20): 3879-88; Hoelzl, M.A., et al. (2017). Dev Biol. 429(1): 132-146).
Immunoprecipitation Analysis: A representative lot immunoprecipitated FoxA2/HNF-3b in Immunoprecipitation applications (van den Brink, G.R., et al. (2001). Gastroenterology. 121(2):317-28).
Immunohistochemistry Applications: A representative lot detected FoxA2/HNF-3b in Immunohistochemistry applications (Ericson, J., et al. (1996). Cell. 87(4):661-73; Kwon, O., et al. (1998). J Clin Invest. 101(10):2054-64; Rousa, F.M., et al. (2000). Mol Cell Biol. 20(21):8264-82; van den Brink, G.R., et al. (2001). Gastroenterology. 121(2):317-28; Camp, D., et al. (2014). Development. 141(20):3879-88; Hoelzl, M.A., et al. (2017). Dev Biol. 429(1):132-146; Amarnath, S., et al. (2017). J Cell Sci. 130(1):119-131).
Immunocytochemistry Analysis: A representative lot detected FoxA2/HNF-3b in Immunohistochemistry applications (Nagase, T., et al. (2009). Dev Dyn. 238(5):1118-30).
Western Blotting Analysis: A representative lot detected FoxA2/HNF-3b in Western Blotting applications (Rousa, F.M., et al. (2000). Mol Cell Biol. 20(21):8264-82; van den Brink, G.R., et al. (2001). Gastroenterology. 121(2):317-28).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Biochem/physiol Actions
Clone 4C7 is a mouse monoclonal antibody that detects Hepatocyte nuclear factor-3β (HNF-3β/FoxA2).
Physical form
Purified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Preparation Note
0.5 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Recommended storage: +2°C to +8°C.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持